Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation
Journal
Open Access Macedonian Journal of Medical Sciences
Date Issued
2016-06-15
Author(s)
Boskov, Vladimir
Risteski, Dejan
DOI
10.3889/oamjms.2016.053
Abstract
In patients with an implanted pacemaker, asymptomatic atrial fibrillation (AF) is associated with an increased risk of thrombo-embolic complications. There is still no consensus which duration of episodes of atrial fibrillation should be taken as an indicator for inclusion of oral anticoagulation therapy (OAC).
